UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000030993
Receipt No. R000035385
Official scientific title of the study Performance comparison of hollow-fiber dialyzers, VPS-VA and VPS-HA
Date of disclosure of the study information 2018/01/31
Last modified on 2018/03/22 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Performance comparison of hollow-fiber dialyzers, VPS-VA and VPS-HA
Title of the study (Brief title) Clinical Study of VPS-VA
Region
Japan

Condition
Condition Chronic Kidney Disease
(End Stage Renal Disease)
Classification by specialty
Nephrology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To demonstrate the beta 2-microglobulin clearance of VPS-VA is higher than that of VPS-HA.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1 Confirmatory
Trial characteristics_2 Pragmatic
Developmental phase Not applicable

Assessment
Primary outcomes Beta 2-microglobulin clearance
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Device,equipment
Interventions/Control_1 Dialysis therapy using VPS-HA for a week.
Hollow-fiber dialyzers will be changed from VPS-HA to VPS-VA.
Dialysis therapy using VPS-VA for two weeks.
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
85 years-old >
Gender Male and Female
Key inclusion criteria 1)Patients on stable maintenance dialysis therapy using VPS-HA at least three months.
2)Patients with capable of dialysis therapy using the type IIa hollow-fiber dialyzer.
3)Patients with capable of obtaining blood flow rate >= 200 mL/min.
4)Patients who are capable to participate in the study as outpatients.
5)Patients capable of understanding the informed consent form.
6)Patients >= 20 years and <85 years of age at the time of informed consent.
Key exclusion criteria 1)Patients requiring another blood purification therapy such as peritoneal dialysis other than hemodiafiltration within this study period.
2)Patients with a medical history of anaphylaxis symptoms caused by polysulfone or polyvinylpyrrolidone (PVP).
3)Patients with a medical history of anaphylaxis symptoms caused by vitamin E-coated membrane.
4)Patients in the opinion of the principal investigator to disqualify from participation.
Target sample size 10

Research contact person
Name of lead principal investigator Kazue Ueki
Organization Toho Hospital, Sanshikai Medical Corporation
Division name Kidney dialysis center
Address 1155 Azami Kasakake-cho, Midori-city, Gunma
TEL 0277-76-6311
Email kueki@toho-hp.jp

Public contact
Name of contact person Masaki Matsumura
Organization Toho Hospital, Sanshikai Medical Corporation
Division name Kidney dialysis center
Address 1155 Azami Kasakake-cho, Midori-city, Gunma
TEL 0277-76-6311
Homepage URL
Email me6341mm@toho-hp.jp

Sponsor
Institute Toho Hospital, Sanshikai Medical Corporation
Institute
Department

Funding Source
Organization ASAHI KASEI MEDICAL CO., LTD.
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2018 Year 01 Month 31 Day

Progress
Recruitment status Completed
Date of protocol fixation
2018 Year 01 Month 30 Day
Anticipated trial start date
2018 Year 02 Month 01 Day
Last follow-up date
2018 Year 03 Month 17 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2018 Year 01 Month 25 Day
Last modified on
2018 Year 03 Month 22 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035385